From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson’s Disease Treatment?
Cells · 30.04.2024 · 13 (9) · 770
DOI: 10.3390/cells13090770 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 30.04.2024. Verfasst von Cristiana Vilela und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Health and Medical Biotechnology Research (TBIO)/Health Research Network (RISE-Health), ESS, Polytechnic of Porto, R. Dr. An…. Hauptthemen laut MEDLINE: Parkinson Disease, Gastrointestinal Microbiome, Brain, Brain-Gut Axis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Santa Casa da Misericórdia de Lisboa, Portuguese Foundation for Science and Technology (FCT).
Abstract (Originalsprache)
Parkinson’s disease (PD) is recognized as the second most prevalent primary chronic neurodegenerative disorder of the central nervous system. Clinically, PD is characterized as a movement disorder, exhibiting an incidence and mortality rate that is increasing faster than any other neurological condition. In recent years, there has been a growing interest concerning the role of the gut microbiota in the etiology and pathophysiology of PD. The establishment of a brain–gut microbiota axis is now real, with evidence denoting a bidirectional communication between the brain and the gut microbiota through metabolic, immune, neuronal, and endocrine mechanisms and pathways. Among these, the vagus nerve represents the most direct form of communication between the brain and the gut. Given the potential interactions between bacteria and drugs, it has been observed that the therapies for PD can have an impact on the composition of the microbiota. Therefore, in the scope of the present review, we will discuss the current understanding of gut microbiota on PD and whether this may be a new paradigm for treating this devastating disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Translational Health and Medical Biotechnology Research (TBIO)/Health Research Network (RISE-Health), ESS, Polytechnic of Porto, R. Dr. António Bernardino de Almeida 400, 4200-072 Porto, Portugal.
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
- ICVS/3B's Associate Lab, PT Government Associated Lab, 4710-057/4805-017 Braga/Guimarães, Portugal.
- i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, R. Alfredo Allen 208, 4200-135 Porto, Portugal.
ORCID-Profile: Cristiana Vilela, Rita Caridade-Silva, Joana Martins-Macedo, Catarina Teixeira, Eduardo D Gomes, Cristina Prudêncio, Mónica Vieira, Fábio G Teixeira
Förderung
- Santa Casa da Misericórdia de Lisboa
- Portuguese Foundation for Science and Technology (FCT)
Zitieren
APA
Vilela, C., Araújo, B., Soares-Guedes, C., Caridade-Silva, R., Martins-Macedo, J., Teixeira, C., Gomes, E. D., Prudêncio, C., Vieira, M., & Teixeira, F. G. (2024). From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson’s Disease Treatment?. Cells, 13(9), 770. https://doi.org/10.3390/cells13090770
Vancouver
Vilela C, Araújo B, Soares-Guedes C, Caridade-Silva R, Martins-Macedo J, Teixeira C, et al. From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson’s Disease Treatment?. Cells. 2024;13(9):770. doi:10.3390/cells13090770
BibTeX
@article{Vilela2024,
author = {Vilela, Cristiana and Araújo, Bruna and Soares-Guedes, Carla and Caridade-Silva, Rita and Martins-Macedo, Joana and Teixeira, Catarina and Gomes, Eduardo D and Prudêncio, Cristina and Vieira, Mónica and Teixeira, Fábio G},
title = {From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson’s Disease Treatment?},
journal = {Cells},
year = {2024},
volume = {13},
number = {9},
pages = {770},
doi = {10.3390/cells13090770}
}
EUVIMED